Olympus to Auction EVIS EXERA Endoscopy System to Hospitals to Benefit Colorectal Cancer Research

Olympus will conduct a benefit auction of one of its EVIS EXERA II 180 HD platforms to bidders at hospitals and clinics across the U.S., beginning May 17, with proceeds going to the Entertainment Industry Foundation’s National Colorectal Cancer Research Alliance to benefit colorectal cancer research, according to an Olympus news release.

Advertisement

The online auction will close at 11:59 p.m. on May 28, at www.olympusamerica180auction.com. Bids start at $50,000 for the total packaged valued at $215,000. The EVIS EXERA II 180 HD platform to be auctioned off includes a cart, light source and processor, keyboard, printer, 26-inch monitor, suction pump, flushing pump, an HD 180 gastroscope, colonoscope, biopsy forceps, polypectomy snares and hemostasis clips, according to the release. The winning bidder will also receive free installation and three months of technical support, along with a one-year warranty.

“We are grateful to Olympus for providing us with the total value of this auction, which will be directly applied to cutting edge research on colorectal cancer, the number two cancer killer among Americans,” Kathleen Lobb, senior vice president of EIF’s NCCRA, said in the release. “Colorectal cancer is one of the most treatable cancers if detected early enough, and is often entirely preventable with appropriate screening. An estimated 50,000 Americans still die every year from this disease. The donation from Olympus will provide important support to researchers pursuing a cure for colorectal cancer.”

Read the release on Olympus’ EVIS EXERA auction.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.